remestemcel-l-rknd
remestemcel-l-rknd is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand name including RYONCIL. Available dosage form: kit.
Drug Details
- Generic Name
- remestemcel-l-rknd
- Brand Names
- RYONCIL
- Application Number
- BLA125706
- Sponsor
- Mesoblast
- NDC Codes
- 12
- Dosage Forms
- KIT
- Routes
- N/A
- Active Ingredients
- N/A
Indications and Usage
1 INDICATIONS AND USAGE RYONCIL is indicated for the treatment of steroid refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older. RYONCIL is an allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older.